Free tool

Quick ANVISA registration complexity assessment

Answer a few questions about your product and get an instant estimate of risk class, eligibility for the reliance pathway (IN 290/2024) and review timeframe.

Preliminary estimate with no regulatory value. Final classification follows RDC 751/2022, RDC 830/2023 and IN 290/2024.